Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial

BACKGROUND: Virus-associated respiratory infections are in the spotlight with the emergence of SARS-CoV-2 and the expanding use of multiplex PCR (mPCR). The impact of molecular testing as a point-of-care test (POCT) in the emergency department (ED) is still unclear. OBJECTIVES: To compare the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouzid, Donia, Casalino, Enrique, Mullaert, Jimmy, Laurent, Odile, Duval, Xavier, Lescure, François Xavier, Peiffer Smadja, Nathan, Tubiana, Sarah, Armand Lefèvre, Laurence, Descamps, Diane, Fidouh, Nadhira, Choquet, Christophe, Lucet, Jean-Christophe, Visseaux, Benoit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460108/
https://www.ncbi.nlm.nih.gov/pubmed/34555158
http://dx.doi.org/10.1093/jac/dkab241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460108/
https://www.ncbi.nlm.nih.gov/pubmed/34555158
http://dx.doi.org/10.1093/jac/dkab241

Ejemplares similares